We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dynavax Technologies (DVAX) in Focus: Stock Moves 9.1% Higher
Read MoreHide Full Article
Dynavax Technologies Corporation (DVAX - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.6000 –$3.5900 in the past one-month time frame, witnessed a sharp increase yesterday.
The upmove came after the company has entered into an agreement with Sinovac Biotech to develop a vaccine to prevent COVID-19.
The company has seen a mixed track record when it comes to estimate revision of no increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Dynavax Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Dynavax Technologies (DVAX) in Focus: Stock Moves 9.1% Higher
Dynavax Technologies Corporation (DVAX - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.6000 –$3.5900 in the past one-month time frame, witnessed a sharp increase yesterday.
The upmove came after the company has entered into an agreement with Sinovac Biotech to develop a vaccine to prevent COVID-19.
The company has seen a mixed track record when it comes to estimate revision of no increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Dynavax Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Dynavax Technologies Corporation Price
Dynavax Technologies Corporation price | Dynavax Technologies Corporation Quote
Investors interested in the Medical – Biomedical and Genetics industry may consider Abeona Therapeutics Inc. , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>